BIOCEPT INC News

Biocept | 8-K: Current report

Oct 20, 2023 06:06 ET

Biocept | 8-K: Current report

Oct 16, 2023 08:53 ET

BIOCEPT INC | 8-K: Biocept Reports Second Quarter 2023 Financial Results

Aug 22, 2023 16:10 ET

Biocept | 8-K: Current report

Jun 21, 2023 16:06 ET

Biocept | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 23, 2023 08:17 ET

Biocept | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 19, 2023 16:47 ET

Biocept | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 16, 2023 16:11 ET

Biocept | 8-K: Current report

May 16, 2023 09:11 ET

Biocept | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 15, 2023 07:00 ET

Biocept | 8-K: Biocept Reports First Quarter 2023 Financial Results

May 15, 2023 06:07 ET

Biocept | DEFR14A: Definitive proxy statement in connection with contested solicitations

Apr 21, 2023 08:30 ET

Biocept | S-1: General form for registration of securities under the Securities Act of 1933

Apr 20, 2023 16:45 ET

Biocept | DEF 14A: Definitive proxy statements

Apr 20, 2023 16:05 ET

Biocept | 8-K: Current report

Apr 17, 2023 16:46 ET

Biocept | 8-K: Current report

Apr 17, 2023 08:01 ET

Biocept | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Apr 10, 2023 17:19 ET

Biocept | 8-K: Current report

Apr 10, 2023 16:05 ET

Biocept | NT 10-K: Others

Apr 3, 2023 08:00 ET

Biocept | 8-K: Current report

Mar 20, 2023 08:00 ET

Biocept | 8-K: Current report

Jan 6, 2023 07:01 ET